662 related articles for article (PubMed ID: 9216841)
1. Steroidal affinity labels of the estrogen receptor. 3. Estradiol 11 beta-n-alkyl derivatives bearing a terminal electrophilic group: antiestrogenic and cytotoxic properties.
Lobaccaro C; Pons JF; Duchesne MJ; Auzou G; Pons M; Nique F; Teutsch G; Borgna JL
J Med Chem; 1997 Jul; 40(14):2217-27. PubMed ID: 9216841
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships of nonisomerizable derivatives of tamoxifen: importance of hydroxyl group and side chain positioning for biological activity.
Murphy CS; Parker CJ; McCague R; Jordan VC
Mol Pharmacol; 1991 Mar; 39(3):421-8. PubMed ID: 2005879
[TBL] [Abstract][Full Text] [Related]
3. Hydroxylated polychlorinated biphenyls (PCBs) as estrogens and antiestrogens: structure-activity relationships.
Connor K; Ramamoorthy K; Moore M; Mustain M; Chen I; Safe S; Zacharewski T; Gillesby B; Joyeux A; Balaguer P
Toxicol Appl Pharmacol; 1997 Jul; 145(1):111-23. PubMed ID: 9221830
[TBL] [Abstract][Full Text] [Related]
4. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
Miller MA; Lippman ME; Katzenellenbogen BS
Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
[TBL] [Abstract][Full Text] [Related]
5. Antiestrogenic potency and binding characteristics of the triphenylethylene H1285 in MCF-7 human breast cancer cells.
Sheen YY; Ruh TS; Mangel WF; Katzenellenbogen BS
Cancer Res; 1985 Sep; 45(9):4192-9. PubMed ID: 4040807
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of B-, C-, and D-ring-substituted estradiol carboxylic acid esters as locally active estrogens.
Labaree DC; Zhang JX; Harris HA; O'Connor C; Reynolds TY; Hochberg RB
J Med Chem; 2003 May; 46(10):1886-904. PubMed ID: 12723952
[TBL] [Abstract][Full Text] [Related]
7. Biological activity and receptor binding of a strongly interacting estrogen in human breast cancer cells.
Reiner GC; Katzenellenbogen BS; Bindal RD; Katzenellenbogen JA
Cancer Res; 1984 Jun; 44(6):2302-8. PubMed ID: 6547074
[TBL] [Abstract][Full Text] [Related]
8. Antiestrogenic activity of hydroxylated polychlorinated biphenyl congeners identified in human serum.
Moore M; Mustain M; Daniel K; Chen I; Safe S; Zacharewski T; Gillesby B; Joyeux A; Balaguer P
Toxicol Appl Pharmacol; 1997 Jan; 142(1):160-8. PubMed ID: 9007045
[TBL] [Abstract][Full Text] [Related]
9. Effect of halogenated substituents on the metabolism and estrogenic effects of the equine estrogen, equilenin.
Liu X; Zhang F; Liu H; Burdette JE; Li Y; Overk CR; Pisha E; Yao J; van Breemen RB; Swanson SM; Bolton JL
Chem Res Toxicol; 2003 Jun; 16(6):741-9. PubMed ID: 12807357
[TBL] [Abstract][Full Text] [Related]
10. Screening for estrogenicity and anti-estrogenicity: a critical evaluation of an MVLN cell-based transactivation assay.
Freyberger A; Schmuck G
Toxicol Lett; 2005 Jan; 155(1):1-13. PubMed ID: 15585354
[TBL] [Abstract][Full Text] [Related]
11. Steroidal affinity labels of the estrogen receptor alpha. 4. Electrophilic 11beta-aryl derivatives of estradiol.
Aliau S; Delettre G; Mattras H; El Garrouj D; Nique F; Teutsch G; Borgna JL
J Med Chem; 2000 Feb; 43(4):613-28. PubMed ID: 10691688
[TBL] [Abstract][Full Text] [Related]
12. Induction of the estrogen specific mitogenic response of MCF-7 cells by selected analogues of estradiol-17 beta: a 3D QSAR study.
Wiese TE; Polin LA; Palomino E; Brooks SC
J Med Chem; 1997 Oct; 40(22):3659-69. PubMed ID: 9357533
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of 4-(hydroxyalkyl)estradiols and related compounds.
Lovely CJ; Bhat AS; Coughenour HD; Gilbert NE; Brueggemeier RW
J Med Chem; 1997 Nov; 40(23):3756-64. PubMed ID: 9371241
[TBL] [Abstract][Full Text] [Related]
14. 2-Phenylbenzo[b]furans: relationship between structure, estrogen receptor affinity and cytostatic activity against mammary tumor cells.
Erber S; Ringshandl R; von Angerer E
Anticancer Drug Des; 1991 Nov; 6(5):417-26. PubMed ID: 1764164
[TBL] [Abstract][Full Text] [Related]
15. Development and characterization of a cell line that stably expresses an estrogen-responsive luciferase reporter for the detection of estrogen receptor agonist and antagonists.
Wilson VS; Bobseine K; Gray LE
Toxicol Sci; 2004 Sep; 81(1):69-77. PubMed ID: 15166400
[TBL] [Abstract][Full Text] [Related]
16. High affinity 17alpha-substituted estradiol derivatives: synthesis and evaluation of estrogen receptor agonist activity.
Kasiotis KM; Mendorou C; Haroutounian SA; Alexis MN
Steroids; 2006 Mar; 71(3):249-55. PubMed ID: 16360721
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens: evidence for an antiproliferative effect of hydroxyferrocifens on both hormone-dependent and hormone-independent breast cancer cell lines.
Top S; Vessières A; Leclercq G; Quivy J; Tang J; Vaissermann J; Huché M; Jaouen G
Chemistry; 2003 Nov; 9(21):5223-36. PubMed ID: 14613131
[TBL] [Abstract][Full Text] [Related]
18. Guide-lines in the design of new antiestrogens and cytotoxic-linked estrogens for the treatment of breast cancer.
Leclercq G; Devleeschouwer N; Heuson JC
J Steroid Biochem; 1983 Jul; 19(1A):75-85. PubMed ID: 6887875
[TBL] [Abstract][Full Text] [Related]
19. Endocrine-responsive pancreatic carcinoma: steroid binding and cytotoxicity studies in human tumor cell lines.
Benz C; Hollander C; Miller B
Cancer Res; 1986 May; 46(5):2276-81. PubMed ID: 3697973
[TBL] [Abstract][Full Text] [Related]
20. Differential interactions of estrogens and antiestrogens at the 17 beta-hydroxy or counterpart function with the estrogen receptor.
Borgna JL; Scali J
Eur J Biochem; 1991 Aug; 199(3):575-85. PubMed ID: 1868844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
